Plasma pharmacokinetics and faecal excretion of ivermectin, doramectin and moxidectin following oral administration in horses
Authors:
- 1 September 2001
- journal article
- research article
- Published by Wiley in Equine Veterinary Journal
- Vol. 33 (5) , 494-498
Abstract
Summary: The present study was carried out to investigate whether the pharmacokinetics of avermectins or a milbemycin could explain their known or predicted efficacy in the horse. The avermectins, ivermectin (IVM) and doramectin (DRM), and the milbemycin, moxidectin (MXD), were each administered orally to horses at 200 μg/kg bwt. Blood and faecal samples were collected at predetermined times over 80 days (197 days for MXD) and 30 days, respectively, and plasma pharmacokinetics and faecal excretion determined. Maximum plasma concentrations (C max ) (IVM: 21.4 ng/ml; DRM: 21.3 ng/ml; MXD: 30.1 ng/ml) were obtained at (t max ) 7.9 h (IVM), 8 h (DRM) and 7.9 h (MXD). The area underthe concentration time curve (AUC) of MXD (92.8 ng.day/ml) was significantly larger than that of IVM (46.1 ng.day/ml) but not of DRM (53.3 ng.day/ml) and mean residence time of MXD (17.5 days) was significantly longer than that of either avermectin, while that of DRM (3 days) was significantly longer than that of IVM (2.3 days). The highest (dry weight) faecal concentrations (IVM: 19.5 μg/g; DRM: 20.5 μg/g; MXD: 16.6 μg/g) were detected at 24 h for all molecules and each compound was detected (≥ 0.05 μg/g) in faeces between 8 h and 8 days following administration. The avermectins and milbemycin with longer residence times may have extended prophylactic activity in horses and may be more effective against emerging and maturing cyathostomes during therapy. This will be dependent upon the relative potency of the drugs and should be confirmed in efficacy studies.Keywords
This publication has 17 references indexed in Scilit:
- Avermectins and milbemycinsJournal of Veterinary Pharmacology and Therapeutics, 1996
- The effect of level of feed intake on the pharmacokinetic disposition and efficacy of ivermectin in sheepJournal of Veterinary Pharmacology and Therapeutics, 1996
- Avermectins and milbemycins against Fasciola hepatica: In vivo drug efficacy and in Vitro receptor bindingInternational Journal for Parasitology, 1995
- Absorption, Tissue Distribution, Metabolism, and Excretion of Moxidectin in CattleJournal of Agricultural and Food Chemistry, 1994
- Relationship between pharmacological properties and clinical efficacy of ruminant anthelminticsVeterinary Parasitology, 1993
- Oral absorption and bioavailability of fenbendazole in the dog and the effect of concurrent ingestion of foodJournal of Veterinary Pharmacology and Therapeutics, 1993
- The distribution and some pharmacokinetic parameters of ivermectin in pigsVeterinary Research Communications, 1992
- Effect of parasitism with Nematodirus battus on the pharmacokinetics of levamisole, ivernectin and netobiminVeterinary Parasitology, 1991
- Absorption, tissue distribution, and excretion of tritium-labeled ivermectin in cattle, sheep, and ratJournal of Agricultural and Food Chemistry, 1990
- The pharmacodynamics of ivermectin in sheep and cattleJournal of Veterinary Pharmacology and Therapeutics, 1988